PROTEOME SCIENCES PLC

Director's Dealing • Mar 22, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6389I

Proteome Sciences PLC

22 March 2018

Proteome Sciences plc

("Proteome Sciences" or the "Company")

Director/PDMR Shareholding

The Company announces that on 21 March 2018 Roger McDowell, a Non-Executive Director of the Company, sold 500,000 ordinary shares of 1 pence each ("Ordinary Shares") at a price of 3 pence per Ordinary Share and bought, into his SIPP, 500,000 Ordinary Shares at a price of 3.006 pence per Ordinary Share (the "Transfer").

Following the Transfer, Mr McDowell's beneficial interest in the Company remains at 2,500,000 Ordinary Shares representing approximately 0.91% of the issued share capital of the Company.

For further information: Proteome Sciences plc
Jeremy Haigh, Chief Executive Officer                       Tel: +44 (0)20 7043 2116
Ian Pike, Chief Scientific Officer
Stefan Fuhrman, Finance Director
finnCap Limited (Nominated Adviser/Broker)
Geoff Nash/James Thompson	Tel: +44 (0)20 7220 0500
Tony Quirke (broking)

About Proteome Sciences plc. (www.proteomics.com):

Proteome Sciences is a leader in applied proteomics offering high sensitivity, proprietary technologies and workflows for mapping cell signalling pathways (SysQuant®) and for the discovery, validation and assay development of protein biomarkers (TMTcalibrator™). The company has its headquarters in London, UK, with laboratory facilities in Frankfurt, Germany from where the PS Biomarker Services™ division provides outsourced proteomics services and proprietary biomarker assays to biopharmaceutical and diagnostics companies and to academia.

Proteome Sciences has patented a number of novel protein biomarkers for diagnostic and treatment applications in important areas of human therapeutics such as cancer, stroke and Alzheimer's disease, and these are available for license.

1.	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Roger McDowell
2.	Reason for the Notification
a)	Position/status	Non-Executive Director
b)	Initial notification/Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Proteome Sciences plc
b)	LEI	213800Q62ICXANKU2986
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the Financial instrument, type of instrument	Ordinary Shares of 1p each
Identification code	GB0003104196
b)	Nature of the transaction	Purchase and sale of shares
c)	Price(s) and volume(s)	500,000 Ordinary Shares bought at 3.006p per Ordinary Share 500,000 Ordinary Shares sold at 3.000p per Ordinary Share
d)	Aggregated information: ·      Aggregated volume ·      Price	500,000 Ordinary Shares bought at 3.006p per Ordinary Share 500,000 Ordinary Shares sold at 3.000p per Ordinary Share
e)	Date of the transaction	21 March 2018
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHSEMFDEFASEFD